The microbiome is the collection of microorganisms, such as bacteria, that naturally live inside us. New research suggests the microbiome determines autism risk.
• The mother’s microbiome, the collection of microscopic organisms that live inside us, determines the risk of autism and other neurodevelopmental disorders in her offspring, new research from the UVA School of Medicine shows.
• The microbiome can be manipulated by changing what we eat, by consuming beneficial bacteria known as probiotics or even by transplanting fecal material from one person to another. This suggests simple ways we might prevent the development of autism.
• The UVA researchers prevented the development of autism-like disorders in mice by blocking an inflammatory molecule produced by the immune system – a molecule already implicated in multiple sclerosis and rheumatoid arthritis.
• The discovery could also offer a way to detect autism early in pregnancy.
The risk of developing autism-spectrum disorders is determined by the mother’s microbiome – the collection of microorganisms that naturally live inside us – during pregnancy, new research from the School of Medicine suggests. The work raises the possibility that preventing forms of autism could be as simple as an expectant mom modifying her diet or taking custom probiotics.
Further, the UVA scientists were able to use their discovery to prevent the development of autism-like neurodevelopmental disorders in lab mice. They found they could halt the development of such disorders by blocking a particular inflammatory molecule produced by the immune system. Targeting this molecule, interleukin-17a, offers another potential avenue for preventing autism in people, the researchers say. They caution, however, that this approach would be much more complex because of the risk of side effects.
“We determined that the microbiome is a key contributor in determining susceptibility [to autism-like disorders], so it suggests that you could target either the maternal microbiome or this inflammatory molecule, IL-17a,” said lead researcher John Lukens, PhD, of UVA’s Department of Neuroscience. “You could also use this [IL-17a] as a biomarker for early diagnosis.”
Microbiome and Autism Risk
The groundbreaking work from Lukens and his colleagues sheds light on the complex relationship between the health of the mother’s microbiome and the healthy development of her children. “The microbiome can shape the developing brain in multiple ways,” explained Lukens, of UVA’s Center for Brain Immunology and Glia (BIG) and UVA’s Carter Immunology Center. “The microbiome is really important to the calibration of how the offspring’s immune system is going to respond to an infection or injury or stress.”
But an unhealthy microbiome in the mom can create problems: Lukens’ work shows that it can make her unborn offspring susceptible to neurodevelopmental disorders. The researchers found that the IL-17a molecule was a key contributor to the development of autism-like symptoms in lab mice.
The good news: The microbiome can be modified easily, either through diet, probiotic supplements or fecal transplant. All of these approaches seek to restore a healthy equilibrium among the different microorganisms that live in the gut.
“In terms of translating our work to humans, I think the next big step would be to identify features of the microbiome in pregnant mothers that correlate with autism risk,” Lukens said. “I think the really important thing is to figure out what kind of things can be used to modulate the microbiome in the mother as effectively and safely as we can.”
Another Option for Preventing Autism
Blocking IL-17a also might offer a way to prevent autism, but Lukens said that path carries much more risk. “If you think about pregnancy, the body is basically accepting foreign tissue, which is a baby,” he said. “As a result, maintenance of embryonic health demands a complex balance of immune regulation, so people tend to shy away from manipulating the immune system during pregnancy.”
IL-17a previously has been implicated in conditions such as rheumatoid arthritis, multiple sclerosis and psoriasis, and there are already drugs available that target it. But Lukens noted that the molecule has an important purpose in stopping infections, especially fungal infections. Blocking it, he said, “could make you susceptible to all kinds of infections.” And doing so during pregnancy could have complex ripple effects on a child’s development that scientists would need to sort out.
For their next steps, Lukens and his team plan to explore the potential role of other immune molecules in the development of autism and other such conditions. IL-17a may be just one piece in a much larger puzzle, he said.
While Lukens’ work links the immune system with neurodevelopmental disorders, he emphasized that this in no way suggests that vaccines are contributing to the development of autism. “There’s a definite link between the immune response and the developing brain,” he said. “It just doesn’t have anything to do with vaccines. It’s much, much earlier.”
Lukens’ work is but the latest research from UVA to speak to the importance of the microbiome in maintaining good health. For example, one of Lukens’ colleagues in the Department of Neuroscience, Alban Gaultier, PhD, found that probiotics in yogurt can reverse depression symptoms.
The Latest on: Autism risk
via Google News
The Latest on: Autism risk
- 'I'm scared. Are you scared?' A Michigan mom's harrowing story of leaving her son with autism to fight COVID-19 alone in the hospitalon December 2, 2020 at 1:26 am
Pam Warfle had to leave her autistic son, who had COVID-19, in the hospital. She begged to stay, to no avail. Then her mom got the virus, too.
- Auditor general says N.S. slow to act on cybersecurity amid increasing riskon December 1, 2020 at 8:30 am
HALIFAX — Nova Scotia’s auditor general says the COVID-19 pandemic is highlighting the need for more robust cybersecurity and anti-fraud measures as government employees are forced to work remotely.
- Large-scale tool to investigate function of autism spectrumon December 1, 2020 at 6:29 am
Scientists at Harvard University the Broad Institute of MIT and Harvard and MIT have developed a technology to investigate the function of many different gene ...
- Scientists use large-scale method to study genes associated with autism spectrum disorderon November 30, 2020 at 9:48 pm
Scientists at Harvard University, the Broad Institute of MIT and Harvard, and MIT have developed a technology to investigate the function of many different genres in many different cell types at once, ...
- A large-scale tool to investigate the function of autism spectrum disorder geneson November 30, 2020 at 12:14 pm
Scientists at Harvard University, the Broad Institute of MIT and Harvard, and MIT have developed a technology to investigate the function of many different genes in many different cell types at once, ...
- Covid could be leaving thousands with undiagnosed autism as uncertainty makes life harder for those on the spectrumon November 29, 2020 at 2:39 am
'Autistic children don’t always cope well with change and it can be really overwhelming when these changes are coming at you thick and fast' ...
- Genetic discovery could lead to better prediction of suicide risk within familieson November 26, 2020 at 7:18 am
Every 11 minutes, an American dies by suicide. That's 132 people a day or more than 48,000 annually. For those left behind, the haunting question is why.
- Your Brain on Cocoa; MS-Gut Link; Autism and Newborn Hearingon November 24, 2020 at 3:30 am
Newborns who later were diagnosed with autism had prolonged auditory brainstem responses. (Autism Research) MedPage Today is committed to improving accessibility for all of its users, and has ...
- Increased Risk Of Chronic Conditions Associated With Early Antibiotic Exposureon November 23, 2020 at 4:10 pm
Researchers have linked early antibiotic use with a greater risk of developing childhood-onset asthma, respiratory allergies, eczema, celiac disease, obesity and attention deficit hyperactivity ...
via Bing News